Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

Uzbekistan has a large burden of drug-resistant tuberculosis (TB). To deal with this public health threat, the National TB Program introduced rapid molecular diagnostic tests such as Xpert MTB/RIF (Xpert) and line probe assays (LPAs) for first-line and second-line drugs. We documented the scale-up o...

Full description

Bibliographic Details
Main Authors: Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov, Laziz Turaev, Khasan Safaev, Kostyantyn Dumchev, Jamshid Gadoev, Oleksandr Korotych, Anthony D. Harries
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Uzbekistan
central Asia
Xpert MTB/RIF
line probe assays
molecular diagnostic tests
nucleic acid amplification tests
Online Access:https://www.mdpi.com/1660-4601/18/9/4685

Internet

https://www.mdpi.com/1660-4601/18/9/4685

Similar Items